Efficacy of Disitamab Vedotin in Non-Small Cell Lung Cancer with HER2 Alterations: a Multicenter, Retrospective Real-World Study
Frontiers in Oncology（2024）
Key words
HER2 mutation,HER2 amplification,target,non-small cell lung cancer,RC48
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined